Characterization of b-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline1avibactam (NXL104)
نویسندگان
چکیده
Results: Overgrowth occurred on agar with low MIC multiples of ceftaroline+avibactam, but frequencies for single-step mutants were ,10. Most mutants were unstable, with only three remaining resistant on subculture. For one, from an CTX-M-15-positive Escherichia coli, the ceftaroline+avibactam MIC was raised, but the organism had reduced resistance to ceftaroline and lost resistance to other oxyimino-cephalosporins, with this profile retained when the mutant blaCTX-M-15 was cloned into E. coli DH5a. Sequencing identified a Lys237Gln substitution in the CTX-M-15 variant. The other two stable single-step mutants were from an AmpC-derepressed Enterobacter cloacae strain; these had unaltered or slightly reduced resistance to other b-lactams. Both had amino acids 213–226 deleted from the V loop of AmpC. Further stable mutants were obtained from AmpC-inducible and -derepressed E. cloacae in multi-step selection, and these variously had reduced expression of OmpC and OmpF, and/or Asn366His/Ile substitutions in AmpC.
منابع مشابه
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
BACKGROUND The beta-lactamase landscape is changing radically, with CTX-M types now the most prevalent extended-spectrum beta-lactamases (ESBLs) worldwide, except maybe in the USA. In addition, there are growing numbers of Enterobacteriaceae with KPC and metallo-carbapenemases. We examined whether combinations of oxyimino-cephalosporins with NXL104, a novel non-beta-lactam beta-lactamase inhibi...
متن کاملIn vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters.
BACKGROUND NXL104 potentiates ceftazidime and ceftaroline against Enterobacteriaceae with extended-spectrum, AmpC, KPC and OXA β-lactamases. We examined whether similar potentiation was obtained against non-fermenters, which are less permeable than Enterobacteriaceae and have more potent efflux. METHODS MICs of ceftazidime+NXL104 (with NXL104 at 4 mg/L) and comparators were determined by CLSI...
متن کاملIn vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
BACKGROUND NXL104 is a novel-structure beta-lactamase inhibitor with potent activity against both class A and class C enzymes. Among the class A carbapenemases, KPC-type enzymes are now spreading rapidly and KPC-related carbapenemase resistance is an emerging phenomenon of great clinical importance. The activity of NXL104 against KPC beta-lactamases was examined. METHODS Enzymatic activity of...
متن کاملImipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins.
Carbapenems such as imipenem and meropenem are not rapidly hydrolyzed by commonly occurring beta-lactamases. Nevertheless, it was possible, by mutagenesis and selection, to isolate mutant strains of Enterobacter cloacae and Proteus rettgeri that are highly resistant to meropenem and imipenem. Two alterations were noted in the E. cloacae mutants. First, the mutant strains appeared to be strongly...
متن کاملActivity of Ertapenem (MK-0826) versus Enterobacteriaceae with Potent -Lactamases
Ertapenem (MK-0826; L-749,345), a new carbapenem with a long serum half-life, was tested, in vitro, against -lactamase-producing bacteria. The new compound had a MIC at which 90% of the isolates were inhibited of 0.06 g/ml for extended-spectrum -lactamase (ESBL)-producing klebsiellas, compared with 0.5 g/ml for imipenem, 16 g/ml for cefepime, and >128 g/ml for ceftazidime and piperacillin-tazob...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2012